EarningsNerd
← Back

ImmunityBio, Inc.

IBRX
$7.79-0.64%

SEC Filings

Recommended10-Q · Aug 4, 2026

Not sure where to start? This is ImmunityBio, Inc.'s most recent filing. Start with its AI summary.

Summarize this filing
10-QRecommendedAug 4, 2026
View on SEC EDGARGenerate Filing Summary
10-QMay 7, 2026
View on SEC EDGARGenerate Filing Summary
10-KFeb 23, 2026
View on SEC EDGARGenerate Filing Summary
10-QNov 5, 2025
View on SEC EDGARGenerate Filing Summary
10-QAug 5, 2025
View on SEC EDGARGenerate Filing Summary
10-QMay 12, 2025
View on SEC EDGARGenerate Filing Summary
10-KMar 3, 2025
View on SEC EDGARGenerate Filing Summary
10-QNov 12, 2024
View on SEC EDGARGenerate Filing Summary
10-QAug 12, 2024
View on SEC EDGARGenerate Filing Summary
10-QMay 9, 2024
View on SEC EDGARGenerate Filing Summary

Showing filings since Nov 12, 2021. Full history on SEC EDGAR